Revolutionary Study on Severe aortopathy caused by Fabry disease.
We are thrilled to announce the publication in the prestigious scientific journal "Circulation", the fundamental study on the severe aortopathy caused by Fabry disease, conducted by a team of illustrious researchers from various prestigious institutions, including our own Aurora Polvani of Technoscience, Pontine Science and Technology Park, Latina, Italy. This study on severe aortopathy caused by Fabry disease was also published in the renowned scientific journal Circulation: Cardiovascular Imaging. In the paper, new cardiac complications associated with Fabry disease are evident and the critical need for timely diagnosis and intervention is underlined.
Understanding Fabry Disease
Fabry disease (FD) is a rare genetic disorder caused by mutations in the α-galactosidase A (AGA) gene, leading to a deficiency or absence of enzyme activity. This deficiency causes the accumulation of globotriaosylceramide (Gb3) in lysosomes, affecting various organs including the heart, kidneys and nervous system. Although Fabry disease is known to cause hypertrophic cardiomyopathy (HCM), this study is the first to document severe aortopathy and aneurysm formation in the aortic root, requiring surgery.
Case Study Highlights
The study described the case of a 62-year-old man with a history of Fabry disease, who developed severe hypertrophic cardiomyopathy and aortic root aneurysm. Despite enzyme replacement therapy (ERT), the patient's condition worsened over the course of 16 years, leading to significant complications including a 56 mm diameter aortic root aneurysm. Cardiovascular Magnetic Resonance (CMR) revealed thickening of the aortic wall and notable accumulation of glycosphingolipids.
Innovative Surgical Intervention
Due to the severity of the aortic aneurysm, the patient underwent a successful reimplantation procedure (David) using a Dacron Valsalva graft. This complex surgery was performed by the expert team from the Department of Cardiac Surgery at the European Hospital and Unicamillus University in Rome, Italy, involving the precise reimplantation of the aortic valve and restoration of the integrity of the aortic root.
Research Collaboration
The groundbreaking study on severe aortopathy caused by Fabry disease was made possible thanks to the collaboration of a team of first-rate researchers from multiple institutions:
- Dr. Andrea Frustaci and Dr. Romina Verardo from IRCCS L. Spallanzani and IRCCS San Raffaele
- Dr. Ruggero De Paulis from the European Hospital
- Dr. Matteo Russo and Dr. Luigi Sansone from San Raffaele University, Rome
- Dr. Manuel Belli from San Raffaele University of Rome
- Dr. Nicola Galea from Sapienza University of Rome
Special recognition goes to Aurora Polvani of Technoscience for her significant contributions to the study.
Implications for Future Research and Treatment
The results of this study highlight the critical need for continued research and improved treatment strategies for Fabry disease. Early and accurate diagnosis, combined with effective therapeutic interventions, are essential to manage and mitigate the serious complications associated with this genetic disorder.
Technoscience is proud to be part of such a significant contribution to the medical field. We remain committed to advancing scientific research and fostering collaborations that lead to breakthrough discoveries. For detailed insights into this study, see the full publication in the journal Circulation https://www.ahajournals.org/journal/circ